MedPath

Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes

Phase 4
Completed
Conditions
Prediabetes (Impaired Fasting Glucose and/or Impaired Glucose Tolerance)
Interventions
Registration Number
NCT01964703
Lead Sponsor
Korea University Anam Hospital
Brief Summary

The purpose of this study is to determine whether Rubus occidentalis extract could improve fasting or postprandial serum glucose levels, and related metabolic markers among patients with prediabetes (impaired fasting glucose and/or impaired glucose tolerance).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  • 19 years of age or older
  • prediabetes (fasting plasma glucose 100-125mg/dl, and/or post 75g OGTT plasma glucose 140-199mg/dl)
Exclusion Criteria
  • pregnant women
  • taking anti-hyperglycemic agents within 3 months at the time of enrollment
  • history of heart failure, myocardial infarction, cerebral infarction
  • uncontrolled hypertension (systolic BP > 160mmHg, or diastolic BP > 100mmHg)
  • serum triglyceride level > 500mg/dl
  • kidney dysfunction (serum Creatinine > 30% of upper normal limits)
  • hepatic dysfunction (AST, ALT > 3 times of upper normal limits)
  • taking systemic glucocorticoids within 1 month

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Rubus occidentalis extract 900mgRubus occidentalis extracttaking Rubus occidentalis extract 900mg/day for 12weeks
Rubus occidentalis extract 1800mgRubus occidentalis extracttaking Rubus occidentalis extract 1800mg/day for 12weeks
Primary Outcome Measures
NameTimeMethod
serum glucose (fasting and post 75g oral glucose tolerance test)12 weeks
Secondary Outcome Measures
NameTimeMethod
serum insulin12 weeks
© Copyright 2025. All Rights Reserved by MedPath